Allay Therapeutics
Therapeutic pain management company
Based in CA
AI Overview
With $100K in lobbying spend across 6 quarterly filings, Allay Therapeutics is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2022 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $70K |
| 2023 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Allay Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Alcohol & Drug Abuse, Health Issues, MED, Pharmacy
Develop and execute a government relations strategy relating to Allay Therapeutics agenda and new drug application (NDA).
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.